share_log
Moomoo 24/7 ·  Apr 23 07:30
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of Lsta1 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment